Incyte and Oxagen Launch Osteoporosis Genetics Program

Jan 29, 2001

NEW YORK, Jan 29 - Incyte and UK-based Oxagen have announced a collaboration, in which the two companies will jointly investigate genes related to osteoporosis for drug target validation and discovery, and Oxagen will receive access to Incyte’s LifeSeq gold database for use in its disease areas, the companies announced Monday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Main menu